Lee Mozessohn - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Lee Mozessohn

Showing results (41-50 of 46) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 46 results.

Current Oncology (Toronto, Ont.)|June 25, 2026

A Prospective Population-Based Study of Chimeric Antigen Receptor T-Cell Therapy for Patients with Diffuse Large B-Cell LymphomaLee Mozessohn, Pierre J A Villeneuve, Nibene H Somé, et al.

British Journal of Haematology|June 1, 2021

Patient-reported fatigue refines prognosis in higher-risk myelodysplastic syndromes (MDS): a MDS-CAN studyIrina Amitai, Michelle Geddes, Nancy Zhu, et al.

Haematologica|August 18, 2022

High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromesJennifer Teichman, Michelle Geddes, Nancy Zhu, et al.

Leukemia & Lymphoma|September 12, 2022

A natural history of lower-risk myelodysplastic syndromes with ring sideroblasts: an analysis of the MDS-CAN registryRena Buckstein, Lisa Chodirker, Lee Mozessohn, et al.

Leukemia & Lymphoma|November 9, 2024

Improvement in quality of life in MDS patients who become transfusion independent after treatmentBo A Wan, Shabbir M H Alibhai, Lisa Chodirker, et al.

Blood Advances|February 11, 2026

ASH 2026 Guidelines for Frontline Management of Acute Lymphoblastic Leukemia in Adolescents and Young AdultsAdam S DuVall, Jennifer McNeer, Matthew C Cheung, et al.

Pageof 5

Search research articles

Showing results (41-50 of 46) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 46 results.

Current Oncology (Toronto, Ont.)|June 25, 2026

A Prospective Population-Based Study of Chimeric Antigen Receptor T-Cell Therapy for Patients with Diffuse Large B-Cell LymphomaLee Mozessohn, Pierre J A Villeneuve, Nibene H Somé, et al.

British Journal of Haematology|June 1, 2021

Patient-reported fatigue refines prognosis in higher-risk myelodysplastic syndromes (MDS): a MDS-CAN studyIrina Amitai, Michelle Geddes, Nancy Zhu, et al.

Haematologica|August 18, 2022

High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromesJennifer Teichman, Michelle Geddes, Nancy Zhu, et al.

Leukemia & Lymphoma|September 12, 2022

A natural history of lower-risk myelodysplastic syndromes with ring sideroblasts: an analysis of the MDS-CAN registryRena Buckstein, Lisa Chodirker, Lee Mozessohn, et al.

Leukemia & Lymphoma|November 9, 2024

Improvement in quality of life in MDS patients who become transfusion independent after treatmentBo A Wan, Shabbir M H Alibhai, Lisa Chodirker, et al.

Blood Advances|February 11, 2026

ASH 2026 Guidelines for Frontline Management of Acute Lymphoblastic Leukemia in Adolescents and Young AdultsAdam S DuVall, Jennifer McNeer, Matthew C Cheung, et al.

Pageof 5